Background Previously, we identified a major myeloid-derived proinflammatory
subpopulation of human blood dendritic cells which we termed slanDCs (eg Schäkel et …

Abstract Dendritic cells (DCs) and Langerhans cells (LC) are professional antigen
presenting cells (APCs) that initiate humoral and cellular immune responses. Targeted …

Binding and uptake of immune complexes (ICs) via low-affinity Fcγ receptors (FcγRs) on
dendritic cells (DCs) is well known as a booster of immune responses. It can be helpful …

Human skin is a preferred vaccination site as it harbors multiple dendritic cell (DC) subsets,
which display distinct C‐type lectin receptors (CLR) that recognize pathogens. Antigens can …

The efficacy of vaccination studies aimed at targeting antigens to human DC-SIGN (hDC-
SIGN) have been notoriously difficult to study in vivo, as eight dendritic cell-specific …

Dendritic cells (DCs) are important initiators of adaptive immunity, and they possess a
multitude of Pattern Recognition Receptors (PRR) to generate an adequate T cell mediated …

Vaccine efficacy is strongly enhanced by antibody-mediated targeting of vaccine
components to dendritic cells (DCs), which are professional antigen presenting cells …

The human skin is an attractive anti-tumor vaccination site due to the vast network of
dendritic cell (DC) subsets that carry antigens to the draining lymph nodes and stimulate …

Delivering antigens directly to dendritic cells (DCs) in situ, by injecting antigens coupled to
antibodies specific for DC surface molecules, is a promising strategy for enhancing vaccine …

Priming of CD8+ T cells by dendritic cells (DCs) is crucial for the generation of effective
antitumor immune responses. Here, we describe a liposomal vaccine carrier that delivers …